← Back to news



Thursday, 22 October 2020

Several members of TRANSCOLONCAN COST Action participate in the ONCOBIOME project funded by European Comission within Horizon 2020 program. The project is based on retro-and pro-spective studies, with large discovery and validation cohorts enrolling >9,000 patients with 4 frequent cancer types across 10 countries.

ONCOBIOME is the first European consortium about microbiota and cancer, and it aims to identify and functionally characterize minimalist commensal ecosystems relevant to cancer, with reliable and robust methods, to validate cancer-associated gut microbiome fingerprints of high clinical relevance, and to develop diagnosis tools that will become part of the oncological arsenal for the optimization and personalization of therapy.